Solazyme Funding Surpasses $76 Million
June 9, 2009 | By Mike Gonet | Filed under: General
Solazyme, Inc., a renewable oil production company and leader in algal synthetic biology, announced that it has surpassed $76 million in funding, which includes a $57 million Series C financing round that just closed. Solazyme uses microalgae biotechnology to produce clean and scalable fuels, “green” chemicals, edible oils and health and wellness products.
